Furthermore, the potent antioxidant melatonin has the ability to improve insulin secretion, normalize glucose levels, reduce IR, and slow the progression of cognitive dysfunction in patients with T2DM and Alzheimer’s disease (AD) [25,26]. The gene discussed is INS; the disease is type 2 diabetes mellitus.